Clinical Neuromuscular Pathology Certification Examination Committee Contributors
Mazen Mohammad Dimachkie, MD, Chair, University of Kansas Medical Center
Disclosures: Received consultancy fees, payment or honoraria for lectures, presentations, manuscript writing or educational events, and participated on a Data Safety Monitoring Board or Advisory Board for Abcuro, Amicus, ArgenX, Astellas, Cabaletta Bio, Catalyst, Covance/Labcorp/Fortrea, Creton Bio Inc, CSL-Behring, Dianthus, Horizon, EMD Serono/Merck, Fortrea, Ig Society, Inc, Janssen, Medlink, Nuvig, Octapharma, Sanofi Genzyme, Shire Takeda, TACT/Treat NMD, Creyon Bio, and Vertex. Received consultancy fees, payment or honoraria for participating on a Data Safety Monitoring Board or Advisory Board for Covance/Labcorp/Fortrea. Received compensation from Oxford University Press, Wolters Kluwer Health/UpToDate, Elsevier. Received grants or research support from Abcuro, Alexion/ AstraZeneca, Alnylam Pharmaceuticals, Amicus, ArgenX, Biosensics, Bristol-Myers Squibb, Cabaletta Bio, Catalyst, CSL-Behring, EMD Serono, FDA/OOPD, GlaxoSmithKline, Genentech, Grifols, Horizon Immnunovant , Mitsubishi Tanabe Pharma, MDA, NIH, Nkarta, Novartis, Octapharma, Orphazyme, Priovant, Ra Pharma/UCB Biopharma, Sanofi Genzyme, Sarepta Therapeutics, Shire Takeda, Spark Therapeutics, and The Myositis Association. Holds/held patents, royalties, or other intellectual property interest from/with a discovery or technology relating to health care from Zevra Therapeutics.
Ahmed Mohamed Attia El-Dokla, Vice Chair, MD, NY Neuromuscular Healthcare, PC
Disclosures: Nothing to disclose.
Lan Zhou, MD, PhD, Hospital for Special Surgery
Disclosures: Nothing to disclose.
Rocio Carolina Garcia Santibanez, MD, Emory Brain Health Center
Disclosures: Nothing to disclose.
Robert Bucelli, MD, Washington University School of Medicine in St. Louis
Disclosures: Self and spouse have equity in Neuroquestions. Serves on advisory board and acts as a consultant for Biogen. Received compensation from Regeneron pharmaceuticals and one-time advisory board for Biogen. Received compensation from LGMD Masterclass as an invited speaker. Received compensation for serving as an expert witness – Rapp v Lebo and Calderon v Compton. Received compensation for serving as site PI for Biogen-sponsored trials in ALS and site PI for the Mitchell syndrome fund at WashU.
Raghav Govindarajan, MD, St. Elizabeth Medical Group
Disclosures: Received compensation for serving as an ad board member for Argenx, UCB, Alexion, Janssen, and Amgen. Received compensation for serving on speakers’ bureau for Argenx, UCB and Alexion. Received royalties from Taylor and Francis for book he authored.
Teerin Liewluck, MD, Mayo Clinic – Rochester
Disclosures: Received personal compensation in the range of $5000 to $9999 for serving on a scientific advisory board for Sarepta Therapeutics, Inc. Received publishing royalties from a publication relating to health care from Springer Nature.
Suur Biliciler, MD, University of Texas Health Science Center
Disclosures: Served on speaker’s bureau for UCB – for Rystiggo© and Zilbrysq©. Served on advisory board for Amgen. Received research support from Reclaiim (PI), Argenx (PI), and Dianthus Therapeutics.
Anthony A. Amato, MD, Brigham and Women's Hospital
Disclosures: Received compensation for serving on Medical Advisory Boards/Consultant for Abcuro, Argenx, EMD Serono, UCB, Horizon Therapeutics, OnoPharma, Alexion, Takeda, and Viridian Therapeutics. Received compensation from DSMB for Medpace, Cabaleta, and Sanofi. Received compensation as Assoc Editor of Neurology. Received compensation as expert witness for several cases for defense and plaintiff. Received NIH grant.
Mohamed Kazamel, MD, Mayo Clinic in Arizona
Disclosures: Served as an expert witness in a case against Clayton Polygraph services. Provided expert opinion on the effect of transthoracic sympathectomy surgeries on pupillary and other autonomic reflexes. Served as consultant for Lloyd, Gray, Whitehead & Monroe, Law Offices, Birmingham, AL.